Outcomes of nontransitioned cases in a sample at ultra-high risk for psychosis

The American Journal of Psychiatry
Ashleigh LinAlison R Yung

Abstract

Two-thirds of individuals identified as at ultra-high risk for psychosis do not develop psychotic disorder over the medium term. The authors examined outcomes in a group of such patients. Participants were help-seeking individuals identified as being at ultra-high risk for psychosis 2-14 years previously. The 226 participants (125 female, 101 male) completed a follow-up assessment and had not developed psychosis. Their mean age at follow-up was 25.5 years (SD=4.8). At follow-up, 28% of the participants reported attenuated psychotic symptoms. Over the follow-up period, 68% experienced nonpsychotic disorders: mood disorder in 49%, anxiety disorder in 35%, and substance use disorder in 29%. For the majority (90%), nonpsychotic disorder was present at baseline, and it persisted for 52% of them. During follow-up, 26% of the cohort had remission of a disorder, but 38% developed a new disorder. Only 7% did not experience any disorder at baseline or during follow up. The incidence of nonpsychotic disorder was associated with more negative symptoms at baseline. Female participants experienced higher rates of persistent or recurrent disorder. Meeting criteria for brief limited intermittent psychotic symptoms at intake was associated with...Continue Reading

Citations

Jun 15, 2015·Psychiatry Research·Irina FalkenbergPaolo Fusar-Poli
Mar 5, 2016·Nature Reviews. Drug Discovery·Mark J MillanDaniel Weinberger
Sep 13, 2015·Early Intervention in Psychiatry·Martina UttingerAnita Riecher-Rössler
Sep 12, 2015·The Lancet. Psychiatry·Dorien H Nieman, Patrick D McGorry
Aug 15, 2015·Schizophrenia Bulletin·Jadon R WebbScott W Woods
Jul 15, 2015·Schizophrenia Bulletin·William T Carpenter, Jason Schiffman
Jul 3, 2016·Schizophrenia Bulletin·Renate L E P ReniersStephen J Wood
Jul 8, 2016·Schizophrenia Bulletin·Johanna T W WigmanAgna A Bartels-Velthuis
Nov 3, 2015·The Lancet. Psychiatry·Philip McGuireAndre Zugman
Oct 23, 2016·L'Encéphale·M-A Crocq
Feb 18, 2017·European Psychiatry : the Journal of the Association of European Psychiatrists·J T W WigmanP de Jonge
Feb 18, 2017·European Psychiatry : the Journal of the Association of European Psychiatrists·P Fusar-PoliP McGuire
Apr 5, 2017·Schizophrenia Research·Jean AddingtonScott W Woods
Jul 4, 2017·The Australian and New Zealand Journal of Psychiatry·Gregor E BergerChristos Pantelis
Sep 18, 2017·European Child & Adolescent Psychiatry·Alice MasilloP Fiori Nastro
Jun 7, 2018·Early Intervention in Psychiatry·Simon RiceBarnaby Nelson
Jul 4, 2018·Early Intervention in Psychiatry·Michael GrossmanChristopher R Bowie
Aug 10, 2018·Psychology and Psychotherapy·Jakob ScheunemannTania M Lincoln
Oct 26, 2018·Evidence-based Mental Health·Patrick D McGorry, Cristina Mei
Oct 30, 2018·The Australian and New Zealand Journal of Psychiatry·Yoo Bin KwakJun Soo Kwon
Aug 12, 2015·Nature Communications·G Paul AmmingerPatrick D McGorry
Jan 1, 2015·Nature Reviews. Disease Primers·René S KahnThomas R Insel
May 18, 2019·British Journal of Sports Medicine·Alan CurrieClaudia L Reardon
Jun 20, 2019·Frontiers in Psychiatry·Marco ArmandoMartin Debbané
Jan 8, 2020·Early Intervention in Psychiatry·Louise B GlenthøjMerete Nordentoft
Dec 18, 2019·Psychiatry and Clinical Neurosciences·Natalie SeilerBrian O'Donoghue

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved